The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Basler, M.
Right arrow Articles by Groettrup, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Basler, M.
Right arrow Articles by Groettrup, M.
The Journal of Immunology, 2004, 173: 3925-3934.
Copyright © 2004 by The American Association of Immunologists

Immunoproteasomes Down-Regulate Presentation of a Subdominant T Cell Epitope from Lymphocytic Choriomeningitis Virus1

Michael Basler*, Nikolay Youhnovski{dagger}, Maries van den Broek{ddagger}, Michael Przybylski{dagger} and Marcus Groettrup2,*

* Division of Immunology, Department of Biology, and {dagger} Laboratory of Analytical Chemistry, Department of Chemistry, University of Constance, Konstanz, Germany; and {ddagger} Institute of Experimental Immunology, Department of Pathology, University Hospital Zürich, Zürich, Switzerland

The cytotoxic T cell response to pathogens is usually directed against a few immunodominant epitopes, while other potential epitopes are either subdominant or not used at all. In C57BL/6 mice, the acute cytotoxic T cell response against lymphocytic choriomeningitis virus is directed against immunodominant epitopes derived from the glycoprotein (gp33–41) and the nucleoprotein (NP396–404), while the gp276–286 epitope remains subdominant. Despite extensive investigations, the reason for this hierarchy between epitopes is not clear. In this study, we show that the treatment of cells with IFN-{gamma} enhanced the presentation of gp33–41, whereas presentation of the gp276–286 epitope from the same glycoprotein was markedly reduced. Because proteasomes are crucially involved in epitope generation and because IFN-{gamma} treatment in vitro and lymphocytic choriomeningitis virus infection in vivo lead to a gradual replacement of constitutive proteasomes by immunoproteasomes, we investigated the role of proteasome composition on epitope hierarchy. Overexpression of the active site subunits of immunoproteasomes LMP2, LMP7, and MECL-1 as well as overexpression of LMP2 alone suppressed the presentation of the gp276–286 epitope. The ability to generate gp276–286-specific CTLs was enhanced in LMP2- and LMP7-deficient mice, and macrophages from these mice showed an elevated presentation of this epitope. In vitro digests demonstrated that fragmentation by immunoproteasomes, but not constitutive proteasomes led to a preferential destruction of the gp276 epitope. Taken together, we show that LMP2 and LMP7 can at least in part determine subdominance and shape the epitope hierarchy of CTL responses in vivo.




This article has been cited by other articles:


Home page
J. Virol.Home page
N. J. Steers, K. K. Peachman, S. R. McClain, C. R. Alving, and M. Rao
Human Immunodeficiency Virus Type 1 Gag p24 Alters the Composition of Immunoproteasomes and Affects Antigen Presentation
J. Virol., July 15, 2009; 83(14): 7049 - 7061.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Riedl, A. Wieland, K. Lamberth, S. Buus, F. Lemonnier, K. Reifenberg, J. Reimann, and R. Schirmbeck
Elimination of Immunodominant Epitopes from Multispecific DNA-Based Vaccines Allows Induction of CD8 T Cells That Have a Striking Antiviral Potential
J. Immunol., July 1, 2009; 183(1): 370 - 380.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Strehl, K. Textoris-Taube, S. Jakel, A. Voigt, P. Henklein, U. Steinhoff, P.-M. Kloetzel, and U. Kuckelkorn
Antitopes Define Preferential Proteasomal Cleavage Site Usage
J. Biol. Chem., June 27, 2008; 283(26): 17891 - 17897.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Hallermalm, K. Seki, A. De Geer, B. Motyka, R. C. Bleackley, M. J. Jager, C. J. Froelich, R. Kiessling, V. Levitsky, and J. Levitskaya
Modulation of the Tumor Cell Phenotype by IFN-{gamma} Results in Resistance of Uveal Melanoma Cells to Granule-Mediated Lysis by Cytotoxic Lymphocytes
J. Immunol., March 15, 2008; 180(6): 3766 - 3774.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. F. Kotturi, B. Peters, F. Buendia-Laysa Jr., J. Sidney, C. Oseroff, J. Botten, H. Grey, M. J. Buchmeier, and A. Sette
The CD8+ T-Cell Response to Lymphocytic Choriomeningitis Virus Involves the L Antigen: Uncovering New Tricks for an Old Virus
J. Virol., May 15, 2007; 81(10): 4928 - 4940.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. D. Robek, M. L. Garcia, B. S. Boyd, and F. V. Chisari
Role of Immunoproteasome Catalytic Subunits in the Immune Response to Hepatitis B Virus
J. Virol., January 15, 2007; 81(2): 483 - 491.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
A. O. Weinzierl, C. Lemmel, O. Schoor, M. Muller, T. Kruger, D. Wernet, J. Hennenlotter, A. Stenzl, K. Klingel, H.-G. Rammensee, et al.
Distorted Relation between mRNA Copy Number and Corresponding Major Histocompatibility Complex Ligand Density on the Cell Surface
Mol. Cell. Proteomics, January 1, 2007; 6(1): 102 - 113.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. C. Pang, M. T. Sanders, J. J. Monaco, P. C. Doherty, S. J. Turner, and W. Chen
Immunoproteasome Subunit Deficiencies Impact Differentially on Two Immunodominant Influenza Virus-Specific CD8+ T Cell Responses
J. Immunol., December 1, 2006; 177(11): 7680 - 7688.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Strehl, T. Joeris, M. Rieger, A. Visekruna, K. Textoris-Taube, S. H. E. Kaufmann, P.-M. Kloetzel, U. Kuckelkorn, and U. Steinhoff
Immunoproteasomes Are Essential for Clearance of Listeria monocytogenes in Nonlymphoid Tissues but Not for Induction of Bacteria-Specific CD8+ T Cells
J. Immunol., November 1, 2006; 177(9): 6238 - 6244.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
I. A. York, M. A. Brehm, S. Zendzian, C. F. Towne, and K. L. Rock
Endoplasmic reticulum aminopeptidase 1 (ERAP1) trims MHC class I-presented peptides in vivo and plays an important role in immunodominance
PNAS, June 13, 2006; 103(24): 9202 - 9207.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Basler, J. Moebius, L. Elenich, M. Groettrup, and J. J. Monaco
An Altered T Cell Repertoire in MECL-1-Deficient Mice.
J. Immunol., June 1, 2006; 176(11): 6665 - 6672.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Chapatte, M. Ayyoub, S. Morel, A.-L. Peitrequin, N. Levy, C. Servis, B. J. Van den Eynde, D. Valmori, and F. Levy
Processing of Tumor-Associated Antigen by the Proteasomes of Dendritic Cells Controls In vivo T-Cell Responses.
Cancer Res., May 15, 2006; 66(10): 5461 - 5468.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
G. Szalay, S. Meiners, A. Voigt, J. Lauber, C. Spieth, N. Speer, M. Sauter, U. Kuckelkorn, A. Zell, K. Klingel, et al.
Ongoing Coxsackievirus Myocarditis Is Associated with Increased Formation and Activity of Myocardial Immunoproteasomes
Am. J. Pathol., May 1, 2006; 168(5): 1542 - 1552.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Osterloh, K. Linkemann, S. Tenzer, H.-G. Rammensee, M. P. Radsak, D. H. Busch, and H. Schild
Proteasomes shape the repertoire of T cells participating in antigen-specific immune responses
PNAS, March 28, 2006; 103(13): 5042 - 5047.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y. Ito, E. Kondo, A. Demachi-Okamura, Y. Akatsuka, K. Tsujimura, M. Tanimoto, Y. Morishima, T. Takahashi, and K. Kuzushima
Three Immunoproteasome-Associated Subunits Cooperatively Generate a Cytotoxic T-Lymphocyte Epitope of Epstein-Barr Virus LMP2A by Overcoming Specific Structures Resistant to Epitope Liberation
J. Virol., January 15, 2006; 80(2): 883 - 890.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Chapiro, S. Claverol, F. Piette, W. Ma, V. Stroobant, B. Guillaume, J.-E. Gairin, S. Morel, O. Burlet-Schiltz, B. Monsarrat, et al.
Destructive Cleavage of Antigenic Peptides Either by the Immunoproteasome or by the Standard Proteasome Results in Differential Antigen Presentation
J. Immunol., January 15, 2006; 176(2): 1053 - 1061.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
D. Bruder, A. K. Nussbaum, D. M. Gakamsky, M. Schirle, S. Stevanovic, H. Singh-Jasuja, A. Darji, T. Chakraborty, H. Schild, I. Pecht, et al.
Multiple synergizing factors contribute to the strength of the CD8+ T cell response against listeriolysin O
Int. Immunol., January 1, 2006; 18(1): 89 - 100.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. K. Nussbaum, M. P. Rodriguez-Carreno, N. Benning, J. Botten, and J. L. Whitton
Immunoproteasome-Deficient Mice Mount Largely Normal CD8+ T Cell Responses to Lymphocytic Choriomeningitis Virus Infection and DNA Vaccination
J. Immunol., July 15, 2005; 175(2): 1153 - 1160.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.